OPTFSNA
ATOS icon

Old Point Trust & Financial Services N A’s Atossa Therapeutics ATOS Stock Holding History

Old Point Trust & Financial Services N A’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17
Closed -$450 – 372
2024
Q1 		$450 Buy
+17
New +$273 ﹤0.01% 494

Other funds holding ATOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Old Point Trust & Financial Services N A's ATOS Position: Q2 2024 in Review

Old Point Trust & Financial Services N A sold out of Atossa Therapeutics (ATOS) in Q2 2024, closing a stake of 17 shares — an estimated $450 sold.

Old Point Trust & Financial Services N A first reported a position in ATOS in Q1 2024 and held it in 1 quarter. The position peaked at $450 in Q1 2024. 77 funds tracked by Wall St. Rank hold ATOS as of Q2 2024.

  • Old Point Trust & Financial Services N A reported no remaining Atossa Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Old Point Trust & Financial Services N A sold 17 Atossa Therapeutics shares in Q2 2024, an estimated $450.
  • Old Point Trust & Financial Services N A first reported a position in Atossa Therapeutics in Q1 2024 and held it in 1 quarter.
  • Old Point Trust & Financial Services N A's Atossa Therapeutics position peaked at $450 in Q1 2024.
  • 77 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2024.

Based on Old Point Trust & Financial Services N A's 13F filing for Q2 2024, filed 13 Aug 2024.